Inspire Medical Systems, Inc. (INSP)
42.44
+0.16
(+0.38%)
USD |
NYSE |
Jun 11, 16:00
42.41
-0.03
(-0.07%)
After-Hours: 20:00
Inspire Medical Systems Gross Profit Margin (Quarterly) : 86.47% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 86.47% |
| December 31, 2025 | 86.59% |
| September 30, 2025 | 85.85% |
| June 30, 2025 | 84.03% |
| March 31, 2025 | 84.75% |
| December 31, 2024 | 84.99% |
| September 30, 2024 | 84.06% |
| June 30, 2024 | 84.76% |
| March 31, 2024 | 84.91% |
| December 31, 2023 | 85.43% |
| September 30, 2023 | 84.10% |
| June 30, 2023 | 83.95% |
| March 31, 2023 | 84.45% |
| December 31, 2022 | 83.94% |
| September 30, 2022 | 81.88% |
| June 30, 2022 | 84.49% |
| March 31, 2022 | 85.58% |
| December 31, 2021 | 85.77% |
| September 30, 2021 | 86.02% |
| June 30, 2021 | 85.80% |
| March 31, 2021 | 85.18% |
| Date | Value |
|---|---|
| December 31, 2020 | 84.44% |
| September 30, 2020 | 85.46% |
| June 30, 2020 | 83.96% |
| March 31, 2020 | 84.56% |
| December 31, 2019 | 84.25% |
| September 30, 2019 | 83.43% |
| June 30, 2019 | 82.84% |
| March 31, 2019 | 82.44% |
| December 31, 2018 | 80.72% |
| September 30, 2018 | 81.10% |
| June 30, 2018 | 80.78% |
| March 31, 2018 | 77.16% |
| December 31, 2017 | 81.11% |
| September 30, 2017 | 78.48% |
| June 30, 2017 | 77.23% |
| March 31, 2017 | 77.42% |
| December 31, 2016 | 76.39% |
| September 30, 2016 | 78.98% |
| June 30, 2016 | 74.39% |
| March 31, 2016 | 73.83% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 78.16% |
| Enovis Corp. | 54.92% |
| IDEXX Laboratories, Inc. | 63.37% |
| Intuitive Surgical, Inc. | 66.05% |
| Kewaunee Scientific Corp. | 26.72% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.45% |
| Return on Assets | 15.72% |
| Return on Invested Capital | 17.65% |
| Profit Margin (Quarterly) | -5.52% |
| Operating Margin (Quarterly) | -0.55% |
| Return on Net Operating Assets | 36.10% |